Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Astellas Pharma Inc
With
Biogen
Patients who completed the initial 24-week treatment course and met the inclusion and exclusion criteria for the 24 week open-label extension continued on their stable MTX dose and also received alefacept throughout this extension.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Psoriatic arthritis
MTX treatment for 3 months prior to enrollment with continuing disease
Normal T-cell count
You may not be if
Other types of psoriasis
History of malignancy or lymphoproliferative disorder
